Variable | Coefficient for non-ethnic minorities | MRS for non-ethnic minorities | Coefficient for dummy variables for ethnic minorities | MRS for ethnic minority patients | Wald test p-values |
---|---|---|---|---|---|
Wait | .0451* | 1 | -.0061 | 1 | Â |
Tiss | .0698* | 1.54* | -.0630** | 0.17 | p<0.0001 |
 |  | (1.19 / 1.90) |  | (−0.82 / 1.17) |  |
Dep | .0595* | 1.32* | .0351* | 2.42* | p=0.2755 |
 |  | (1.05 / 1.59) |  | (1.40 / 3.44) |  |
Age | .0071* | 0.16* | -.0011 | 0.15* | p=0.0024 |
 |  | (0.12 / 0.20) |  | (0.03 / 0.27) |  |
dis1 | .0039 | 0.09 | -.0398 | −0.92 | p=0.6014 |
 |  | (−0.98 / 1.15) |  | (−4.41 / 2.57) |  |
dis2 | .7158* | 15.86* | -.3153** | 10.25* | p<0.0001 |
 |  | (13.87 / 17.85) |  | (4.96 / 15.53) |  |
ill1 | -.1085* | −2.40* | -.0903 | −5.08* | p=0.9050 |
 |  | (−1.06 / -3.74) |  | (−0.83 / -9.33) |  |
ill2 | .1773* | 3.93* | .0647 | 6.19* | p=0.2558 |
 |  | (2.82 / 5.03) |  | (2.51 / 9.88) |  |
Intercepts | .1269* | Â | -.0510 | Â | Â |
Variable | Non-ethnic minorities trade-off between variable & 1 year wait | Non-ethnic minorities trade-off between variable & 5 year wait | Ethnic minority trade-off between variable & 1 year wait | Ethnic minority trade-off between variable & 5 year wait | Â |
Prioritizing perfect not favourable tissue matches | 1.54* | 0.31* | 0.17 | 0.35 | Â |
 | (1.19 / 1.90) | (0.24 / 0.38) | (−0.82 / 1.17) | (−0.16/ 0.23) |  |
Prioritizing favourable not non- favourable tissue matches. | 4.64* | 0.93* | 0.52 | 0.10 | Â |
 | (3.57 / 5.70) | (0.71 / 1.14) | (−2.46 / 3.50) | (−0.49 / 0.70) |  |
Prioritizing a recipient with dependents – per extra dependent | 1.32* | 0.26* | 2.42** | 0.48* |  |
 | (1.05 / 1.59) | (0.21 / 0.32) | (1.40 / 3.44) | (0.28 / 0.69) |  |
prioritizing a younger recipient – per year younger | 0.16* | 0.03* | 0.15* | 0.03* |  |
 | (0.12 / 0.20) | (0.02 / 0.04) | (0.03 / 0.27) | (0.01 / 0.05) |  |
Prioritizing those with no not moderate diseases affecting life expectancy | 0.09 | 0.02 | −0.92 | −0.18 |  |
 | (−0.98 / 1.15) | (−0.20 / 0.23) | (−4.41 / 2.57) | (−0.88 / 0.51) |  |
Prioritizing those with moderate not severe diseases affecting life expectancy | 15.86* | 3.17* | 10.25* | 2.05* | Â |
 | (13.87 / 17.85) | (2.77 / 3.57) | (4.96 / 15.53) | (0.99 / 3.11) |  |
Prioritizing those with no not moderate diseases affecting QoL | −2.40* | −0.48* | −5.08* | −1.02* |  |
 | (−1.06 / -3.74) | (−0.21 / -0.75) | (−0.83 / -9.33) | (−0.17 / -1.87) |  |
Prioritizing those with moderate not severe diseases affecting QoL | 3.93* | 0.79* | 6.19* | 1.24* | Â |
 | (2.82 / 5.03) | (0.56 / 1.01) | (2.51 / 9.88) | (0.50 / 1.98) |  |